Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...
Alta Equipment Group Announces Third Quarter 2024 Financial Results
LIVONIA, Mich., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta”, "we", "our" or the “Company”), a leading provider of premium material handling, construction and ...
Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...